Trial intelligence / Profile preview

Methadone dose variability biomarkers study in opioid dependence substitution treatment

2007-007662-37Phase 4Active

Sponsor
Assistance publique - Hôpitaux de Paris
Start
Apr 2008
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of methadone in opioid use disorder (OUD), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Main analysis. Started Apr 2008; status: active.

02

Drugs

methadone
03

Conditions

opioid use disorder (OUD)

Beyond the preview

Go deeper on 2007-007662-37.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-007662-37.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call